Experienced in Teratoma of the Mediastinum

Taku Omata

Yachiyo, JP 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Teratoma of the Mediastinum
Yachiyo, JP 
OverviewLocationsClinical Research

Overview

Taku Omata practices in Yachiyo, Japan. Mr. Omata is rated as an Experienced expert by MediFind in the treatment of Teratoma of the Mediastinum. His top areas of expertise are Pelizaeus-Merzbacher Disease, Cockayne Syndrome Type 1, Cockayne Syndrome Type 2, and Cockayne Syndrome.

His clinical research consists of co-authoring 31 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Teratoma of the Mediastinum.

Gender
Male

Locations

Yachiyo, Japan
Other Locations
Chiba, Japan
Heta, 2660007, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
A Prospective, Long-Term Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Enrollment Status: Recruiting
Publish Date: January 31, 2025
Intervention Type: Drug, Other

31 Total Publications

Response to the letter to the editor titled "diagnostic clarification and exclusion of differential diagnoses in pediatric acute encephalopathy" regarding: "National study on pediatric acute encephalopathy in Japan (April 2020 to October 2023): Insights from the third study".
Response to the letter to the editor titled "diagnostic clarification and exclusion of differential diagnoses in pediatric acute encephalopathy" regarding: "National study on pediatric acute encephalopathy in Japan (April 2020 to October 2023): Insights from the third study".
Journal: Brain & development
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Omata's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile